Goodrx Holdings Inc (OQ:GDRX)

Sector:  Technology Industry:  Internet Services
 
See Regulatory Filings on SEC
Company Contact
Address: 2701 Olympic Boulevard, Suite 990
SANTA MONICA CA 90404
Tel: N/A
Website: https://investors.goodrx.com
IR: See website
<
Key People
Trevor Bezdek
Chairman of the Board, Co-Founder
Scott W. Wagner
Interim Chief Executive Officer
Douglas Joseph Hirsch
Co-Founder, Chief Mission Officer, Director
Karsten Voermann
Chief Financial Officer
Bansi J. Nagji
President - Healthcare
Raj Beri
Chief Operating Officer
Andrew Slutsky
Senior Vice President - Strategic Marketing Innovation , Chief Marketing Officer
Romin Nabiey
Chief Accounting Officer
 
Business Overview
GoodRx Holdings, Inc. provides a consumer-focused digital healthcare platform in the United States. It offer consumers free access to transparent and lower prices for generic and brand medications, as well as comprehensive healthcare research and information. It also equips healthcare professionals to find and prescribe affordable medications. It offers information and tools to help consumers compare prices and save on their prescription drug purchases. It operates a price comparison platform that provides consumers with geographically relevant prescription pricing and provides access to negotiated prices through its codes that can be used to save money on prescriptions across the United States (the prescription transactions offering). It also offers other healthcare products and services, including pharmaceutical manufacturer solutions, subscriptions, and telehealth services. Its subscription offerings provide additional benefits to consumers of its prescription transactions offering.
Financial Overview
For the fiscal year ended 31 December 2023, Goodrx Holdings Inc revenues decreased 2% to $750.3M. Net loss decreased 73% to $8.9M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Lower net loss reflects Advertising Expense decrease of 12% to $198.8M (expense), Acquisition Cost of Group Companies decrease of 93% to $1.8M (expense).
Employees: 694 as of Dec 31, 2023
Reporting Currency: U.S. Dollars
Enterprise value: $2,789M as of Dec 31, 2023
Annual revenue (TTM): $750.27M as of Dec 31, 2023
EBITDA (TTM): $120.91M as of Dec 31, 2023
Net annual income (TTM): -$8.87M as of Dec 31, 2023
Free cash flow (TTM): $82.53M as of Dec 31, 2023
Net Debt Last Fiscal Year: N/A
Shares outstanding: 394,997,372 as of Feb 20, 2024
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization

Thank you for visiting InsiderTracking.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you wish to consider using a browser that blocks ads, please log in or subscribe.

Alternatively, if you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). If you are in private browsing mode and do not want to subscribe, please disable tracking protection while visiting our website.

Thank you for using Insider Tracking.